Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Business leaders impressed with our university
2011-08-18

 

David Nkwenkweza, an employee of the Unit for Students with Disabilities at the UFS, with from the left: Gerhard Joubert, Head: Group Marketing and Stakeholder Relations at PPS Insurance; Tsholo Diale, Corporate Social Investment Manager at Afrisam, and Mpho Letlapo CEO of the Sasol Inzalo Fund
Photo: Phelekwa Mpono

Business leaders from some of South Africa’s top companies visited our Bloemfontein Campus on Tuesday, 16 August 2011. Business leaders, which included chief executive officers (CEOs) and top managers from companies, such as Intel, First National Bank and Mediclinic flew in from Johannesburg. They were taken on a trip around campus, meeting university staff and students.

The purpose of the visit was to introduce them to the UFS and some of its projects. It was furthermore to share ideas about what role the university need to play in preparing future leaders for the market place.
 
Walking around campus, the group of business leaders visited the different faculties, some departments, as well as the bustling Thakaneng Student Centre.
 
Ms Mpho Lethlapo, CEO of the Sasol Inzalo Fund, said the UFS campus was different from what she had envisioned. She was impressed with our Unit for Students with Disabilities and said the outstanding facilities at the unit were a necessity as people with disabilities form part of society.
 
Mr Pule Mokoena, Group Executive: Sales and Marketing of Innovation said his trip to the university was an eye-opener as he had certain perceptions about the university. He expressed admiration towards Prof. Jonathan Jansen, Vice-Chancellor and Rector, and said his outlook towards learning was commendable. Mr Mokoena furthermore said the people on the UFS campus were more open-minded than what he had expected and said everywhere he went staff said they only wanted what was best for their students. According to Mr Mokoena, Kovsie students are the type of graduates business leaders want to employ.
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept